Tell your doctor if have hereditary fructose intolerance.ĭo not take idarucizumab if you are allergic to idarucizumab or to any of its ingredients. Patients with hereditary fructose intolerance may be at risk of adverse reactions such as low blood sugar, low phosphate, metabolic acidosis, increase in uric acid, and acute liver failure. PRAXBIND is indicated in patients treated with Pradaxa when reversal of the anticoagulant effects of dabigatran is needed: For emergency surgery/urgent. Hereditary Fructose Intolerance to Sorbitol Excipient. Idarucizumab contains sorbitol.These may include fever, difficulty breathing due to tightening of the airways, hyperventilation, rash, and itching, Your doctor will discontinue idarucizumab if this occurs. Hypersensitivity reactions (serious allergic reaction).Some patients may require an additional dose of idarucizumab. Recurrence of bleeding and increase in coagulation parameters. After structured results have been posted, all regulatory activities are completed in the US and EU for the product and indication, and after the primary.
Your doctor will resume Pradaxa as soon as medically appropriate. Pradaxa treatment can be initiated 24 hours after administration of idarucizumab. Blood clots. Idarucizumab reverses Pradaxa so patients are at exposed to the thrombotic risk (blood clots) of the underlying disease that Pradaxa is being given for.Serious side effects have been reported with idarucizumab including the following: INDICATIONS AND USAGE Pradaxa® (dabigatran etexilate mesylate) capsules is indicated: to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation for the.
0 kommentar(er)
